APA (7th ed.) Citation

Parvin Begum, P., Wanyuan Cui, M., & Sanjay Popat, P. (2022). Crizotinib-Resistant ROS1 G2101A Mutation Associated With Sensitivity to Lorlatinib in ROS1-Rearranged NSCLC: Case Report. Elsevier.

Chicago Style (17th ed.) Citation

Parvin Begum, PhD, MBBS Wanyuan Cui, and PhD Sanjay Popat. Crizotinib-Resistant ROS1 G2101A Mutation Associated With Sensitivity to Lorlatinib in ROS1-Rearranged NSCLC: Case Report. Elsevier, 2022.

MLA (9th ed.) Citation

Parvin Begum, PhD, et al. Crizotinib-Resistant ROS1 G2101A Mutation Associated With Sensitivity to Lorlatinib in ROS1-Rearranged NSCLC: Case Report. Elsevier, 2022.